| |
| |
|
| Insider
Information: |
Cole Douglas G. |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
37,053 |
|
|
Indirect Shares
|
395,565 |
|
|
| Direct
Value |
$584,874 |
|
|
|
Indirect Value
|
$5,933,475 |
|
|
| Total
Shares |
432,618 |
|
|
| Total
Value |
$6,518,349 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aveo Pharmaceuticals Inc |
AVEO |
Director |
2010-03-17 |
0 |
2011-05-16 |
395,565 |
Premium* |
|
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2016-08-10 |
2,778 |
2014-06-23 |
0 |
Premium* |
|
|
Editas Medicine, Inc. |
EDIT |
Director |
2017-08-17 |
3,171 |
2016-08-11 |
0 |
Premium* |
|
|
Quanterix Corp |
QTRX |
|
2019-01-02 |
4,540 |
2018-08-07 |
0 |
Premium* |
|
|
Denali Therapeutics Inc. |
DNLI |
Director |
2023-06-01 |
26,564 |
2021-06-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,216 |
26,564 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2022-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
5,986 |
22,348 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,074 |
5,327 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2021-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,253 |
3,253 |
0 |
- |
|
| QTRX |
Quanterix Corp |
|
– • – |
2019-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,270 |
4,540 |
0 |
- |
|
| QTRX |
Quanterix Corp |
Director |
– • – |
2018-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,270 |
2,270 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Director |
– • – |
2017-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,686 |
3,171 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Director |
– • – |
2016-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,485 |
1,485 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2016-08-10 |
4 |
A |
$0.00 |
$0 |
D/D |
917 |
2,778 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2014-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,861 |
1,861 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2011-05-16 |
4 |
AS |
$17.98 |
$943,664 |
I/I |
(52,492) |
395,565 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2011-05-13 |
4 |
AS |
$17.75 |
$1,444,801 |
I/I |
(81,389) |
445,065 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2011-05-12 |
4 |
AS |
$17.30 |
$278,912 |
I/I |
(16,119) |
521,815 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2011-03-17 |
4/A |
A |
$0.00 |
$0 |
I/I |
819,915 |
819,915 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2011-01-03 |
4 |
AS |
$14.53 |
$92,995 |
I/I |
(6,400) |
600,248 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2010-12-31 |
4 |
AS |
$14.56 |
$283,748 |
I/I |
(19,493) |
606,284 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2010-12-30 |
4 |
AS |
$14.62 |
$95,038 |
I/I |
(6,500) |
624,668 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2010-12-29 |
4 |
AS |
$14.50 |
$204,577 |
I/I |
(14,112) |
630,798 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2010-12-28 |
4 |
AS |
$14.62 |
$142,355 |
I/I |
(9,735) |
644,106 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2010-12-27 |
4 |
AS |
$14.53 |
$133,633 |
I/I |
(9,196) |
653,286 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2010-12-23 |
4 |
AS |
$14.60 |
$69,576 |
I/I |
(4,765) |
661,958 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2010-12-22 |
4 |
AS |
$14.68 |
$256,923 |
I/I |
(17,500) |
666,451 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2010-12-21 |
4 |
AS |
$14.29 |
$211,464 |
I/I |
(14,800) |
682,954 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2010-12-20 |
4 |
AS |
$14.11 |
$289,290 |
I/I |
(20,500) |
696,910 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2010-12-17 |
4 |
AS |
$14.07 |
$162,466 |
I/I |
(11,549) |
716,242 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
